Search

everythinglearnresearchcommunity

for

Search:↓

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Spironolactone may help reduce hair loss in androgenic alopecia.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Baldness may lower the risk of testicular cancer.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Woodhouse-Sakati syndrome can cause writer's cramp and other varied symptoms, highlighting the importance of genetic testing for diagnosis.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The conclusion is that a more comprehensive and precise approach is needed for diagnosing PCOS to address its broader health risks.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Fluridil safely promotes hair growth in men with androgenetic alopecia.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.